Detalles de la búsqueda
1.
Anti-Inflammatory Effects of the Iron Chelator, DIBI, in Experimental Acute Lung Injury.
Molecules
; 27(13)2022 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35807282
2.
Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles' heel of antibiotic-resistant microbes.
Environ Chem Lett
; 19(4): 2789-2808, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33907538
3.
Iron Sequestrant DIBI, a Potential Alternative for Nares Decolonization of Methicillin-Resistant Staphylococcus aureus, Is Anti-infective and Inhibitory for Mupirocin-Resistant Isolates.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31907189
4.
Enhanced Fe3+ binding through cooperativity of 3-hydroxypyridin-4-one groups within a linear co-polymer: wrapping effect leading to superior antimicrobial activity.
Biometals
; 33(6): 339-351, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33074473
5.
Potential Mechanisms of Mucin-Enhanced Acinetobacter baumannii Virulence in the Mouse Model of Intraperitoneal Infection.
Infect Immun
; 87(11)2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31405959
6.
Antibiotic-Resistant Acinetobacter baumannii Is Susceptible to the Novel Iron-Sequestering Anti-infective DIBI In Vitro and in Experimental Pneumonia in Mice.
Antimicrob Agents Chemother
; 63(9)2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31209004
7.
DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage.
Biometals
; 32(6): 909-921, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31624972
8.
Iron Chelation as Novel Treatment for Interstitial Cystitis.
Pharmacology
; 103(3-4): 159-162, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30695781
9.
Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis.
Antimicrob Agents Chemother
; 62(8)2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29844048
10.
Anti-inflammatory and anti-bacterial effects of iron chelation in experimental sepsis.
J Surg Res
; 200(1): 266-73, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26235905
11.
Inhibitory effect of iron withdrawal by chelation on the growth of human and murine mammary carcinoma and fibrosarcoma cells.
Exp Mol Pathol
; 99(2): 262-70, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26210486
12.
Erratum for Savage et al., "Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis".
Antimicrob Agents Chemother
; 63(2)2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30696693
13.
Dysregulated Iron Homeostasis as Common Disease Etiology and Promising Therapeutic Target.
Antioxidants (Basel)
; 12(3)2023 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36978919
14.
Iron Chelation as a Potential Therapeutic Approach in Acute Lung Injury.
Life (Basel)
; 13(8)2023 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37629516
15.
Iron Withdrawal with DIBI, a Novel 3-Hydroxypyridin-4-One Chelator Iron-Binding Polymer, Attenuates Macrophage Inflammatory Responses.
Adv Pharm Bull
; 13(2): 368-377, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37342371
16.
Iron Chelator DIBI Suppresses Formation of Ciprofloxacin-Induced Antibiotic Resistance in Staphylococcus aureus.
Antibiotics (Basel)
; 11(11)2022 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36421286
17.
Antimicrobial Activity of the Iron-Chelator, DIBI, against Multidrug-Resistant Canine Methicillin-Susceptible Staphylococcus pseudintermedius: A Preliminary Study of Four Clinical Strains.
Pathogens
; 11(6)2022 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35745511
18.
Comparison of Treatment Effects of Different Iron Chelators in Experimental Models of Sepsis.
Life (Basel)
; 11(1)2021 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33466819
19.
Anti-inflammatory iron chelator, DIBI, reduces leukocyte-endothelial adhesion and clinical symptoms of LPS-induced interstitial cystitis in mice.
Clin Hemorheol Microcirc
; 79(3): 395-406, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34250933
20.
Iron should be restricted in acute infection.
Front Biosci (Landmark Ed)
; 25(4): 673-682, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31585910